Working with Genetically Modified Organisms GMOs - PowerPoint PPT Presentation

1 / 37
About This Presentation
Title:

Working with Genetically Modified Organisms GMOs

Description:

The object of this Act is to protect the health and safety of people, and to ... GM derived therapeutic products. Human therapeutic product safety ... – PowerPoint PPT presentation

Number of Views:94
Avg rating:3.0/5.0
Slides: 38
Provided by: philip203
Category:

less

Transcript and Presenter's Notes

Title: Working with Genetically Modified Organisms GMOs


1
Working with Genetically Modified Organisms
(GMOs)
2
Genetically Modified Organism (GMO)
  • An organism modified by gene technology.
  • An organism that has inherited particular traits
    from an organism (the initial organism) being
    traits that occurred in the initial organism
    because of gene technology.
  • Anything declared by the regulations to be a
    genetically modified organism, or that belongs to
    a class of things declared by the regulations to
    be a genetically modified organism.

3
ENIGMAS!
If DNA is taken from an organism, spliced to a
vector, and replaced in the same organism, then
that organism is a GMO.
Just because an organism is not considered to be
a GMO in another jurisdiction (USA,. EU) does not
mean it is not a GMO in Australia.
Just because someone else has permission to work
with a GMO does not mean that you do. You still
have to apply for permission.
Although you may not have constructed the GMO, if
you are working with it you still have to apply
for permission.
Plant, animal, or fungal cells containing
recombinant DNA are considered to be GMOs.
4
What is not a GMO?
  • Does not include
  • mutants.
  • fusion of animal cells unless the product can
    form an animal.
  • plants formed x protoplast fusion.
  • plants formed by embryo rescue or invitro
    fertilisation or zygote implantation.
  • organisms formed by natural DNA transfer.

5
History of GMO regulation in Australia.
  • Genetic Manipulation Advisory Committee (GMAC)
    1980s-2001
  • Established regulatory framework for regulating
    research with GMOs.
  • Carried out assessment of proposals.
  • Provided advice on containment conditions.
  • No statutory powers

6
The Gene Technology Act 2000
  • Establishes a uniform regulatory system
    throughout the states and territories.
  • The object of this Act is to protect the health
    and safety of people, and to protect the
    environment, by identifying risks posed by or as
    a result of gene technology, and by managing
    those risks through regulating certain dealings
    with GMOs.

7
Purpose
  • To ensure that all work with Genetically
    Manipulated Organisms (GMOs) within Australia is
    carried out in such a way that threats to human
    health and the environment are minimised.

8
The Regulator.
  • To administer the regulations under the act, the
    Federal government established the Office of the
    Gene Technology Regulator (OGTR).
  • The OGTR is a statutory office-holder
    independent from commercial or political
    influences.
  • The regulator cannot be directed by anyone when
    making a decision on whether to grant a licence.
  • Reports direct to Fed Health Minister.
  • Currently Dr Sue Meek.

9
Structure of OGTR
GTR
Policy Compliance Branch
Evaluation Branch
  • Secretariat
  • Policy Section
  • Business Management
  • IT section
  • Monitoring Compliance
  • Legal section
  • 2 evaluation teams
  • Contained dealing
  • section.
  • Review section

Gene Technology Technical Advisory Committee
(GTTAC) Gene Technology Ethics Committee
(GTEC) Community Consultative Committee (CCC)
10
Function of GTTAC
  • To provide scientific and technical advice on
  • Gene technology, GMO and GMO products
  • Applications made under the act
  • The biosafety aspects of gene technology
  • The need for policy principles, policy
    guidelines, in relation to GMOs and GMO products
    and the content of such principles guidelines and
    codes.

11
Role of the CCC
  • To provide advice on
  • Matters of general concern in relation to
    applications made under this act.
  • Matters of general concern in relation to GMOs
  • The need for policy principles, guidelines, codes
    of practice and technical and procedural
    guidelines in relation to GMOs and GM products.
  • The content of such principles guidelines and
    codes.

12
Function of GTEC
  • To provide advice on
  • Ethical issues relating to Gene Technology
  • The need for, and content of Codes of Practice in
    relation to ethics in respect of dealings with
    GMOs
  • The need for and content of policy principles in
    relation to dealings with GMOs that should not be
    conducted for ethical reasons.

13
Relationship between OGTR and other regulatory
agencies.
14
Interaction between OGTR and other regulatory
agencies.
15
Operation of the Act
FEDERAL HEALTH MINISTER
OGTR
CEO (VC or PVCR)
IBC
RESEARCHERS
16
Organisations.
  • All organizations involved in dealings are
    accredited by the OGTR.
  • Every accredited organisation has access to an
    Inst. Biosafety Committee (IBC) which monitors
    compliance with the regulations within that
    organisation.

17
Role of the IBC
  • Maintains a register of all researchers and
    projects.
  • Processes applications to work with GMOs.
  • Notifies the OGTR of all such work.
  • Ensures compliance with regulations.
  • Carries out inspection of facilities.
  • Provides training to researchers.
  • Provides an annual report to the OGTR.
  • Advises the CEO on matters relating to dealings
    with GMOs within that organisation.

18
Statutory Requirements
  • All dealings with GMOs no matter how trivial
    must be notified to the OGTR through the
    organisations IBC.
  • All personnel dealing with GMOs must attend a
    training course.
  • Dealings must only be carried out in certified
    premises unless permission is given for other
    facilities (eg., DIRs)
  • Failure to notify will incur penalties.

19
Penalties
  • For dealing without a licence.
  • fines up to 55,000
  • imprisonment for 2 years
  • Aggravated offence.
  • fine of 1.1m
  • imprisonment up to 5 years.

20
More Likely Penalties
  • Loss of accreditation by organisation.
  • corporate culture of non-compliance.
  • Rejection of subsequent applications.
  • breaches must be indicated on each proposal.
  • Adverse publicity.
  • breaches of the regulations are reported in
    parliament.

21
RESPONSIBILITIES I The Organisation
  • CEO (or delegate) is responsible to ensure
  • Adequate staffing and resources are available to
    maintain quality assurance systems for
    compliance.
  • A competent indemnified IBC is part of the
    quality assurance system.
  • That facilities are appropriate for the conduct
    of work with GMOs.

22
RESPONSIBILITIES II Heads of Schools/Sections.
  • Ensure safe working procedures are understood and
    enforced.
  • Involves provision of training to new researchers
    and
  • Requires compliance by researchers.

23
RESPONSIBILITIES III Principal Researchers
  • Ensure safe working and GM procedures are
    understood and enforced.
  • Provide an SOP manual.
  • Ensure that all dealings are licenced/ notified.
  • Ensure that all staff are aware of specific
    licence conditions.
  • Advise the IBC immediately of breaches of
    conditions/regulations, unexplained illnesses or
    absences or changes to dealings (names of new
    staff).
  • Maintain a register of all GM projects.
  • Inform IBC when projects terminate.

24
RESPONSIBILITIES IV Researchers.
  • Undertake GTR training.
  • Adhere to SOPs for GM facilities.
  • Notify your supervisor or the IBC of any hazards,
    incidents or injuries.
  • Notify your supervisor and the IBC of any changes
    to the project.
  • Check that your project has been notified to the
    IBC.

25
RESPONSIBILITIES V IBC
  • Maintain a register of all dealings and staff.
  • Maintaining a list of facilities.
  • Inspecting facilities.
  • Provide training.
  • Assess proposals and advise CEO.
  • Liase with OGTR.
  • Provide an annual report to OGTR.
  • Develop procedures to ensure compliance

26
Facilities
  • All work with GMOs (except emempt dealings) must
    be carried out in certified premises
  • Apply to OGTR to have facilities approved
  • Facilities must conform to the standards
    specified in ASNZ standards 2243.3 2002
  • Facilities must be inspected every year by the
    IBC.
  • Facilities will also be spot inspected by OGTR
  • Work practices must conform to ASNZ std 2243.3
    2002

27
Required work practices for certified labs!
Access to the lab is restricted to authorised
personnel.
Must always wear a lab coat and remove it before
leaving the lab.
Must wash hands before leaving the lab.
If storing cultures outside the facility they
must be stored in an unbreakable container in a
lockable fridge/freezer/room.
If transporting GM material between facilities or
to the autoclave they must be contained in an
unbreakable container.
Any breaches of containment must be reported to
the IBC immediately.
28
If I fail to notify how would they find out?
  • Published papers.
  • Theses
  • Annual Report from University.
  • Information from funding agencies.
  • Conference presentations.
  • Press releases.
  • Informants

29
Types of Dealings
  • Exempt
  • Notifiable Low Risk Dealing (NLRD).
  • Dealings Not Involving Release (DNIR).
  • Dealings Involving Release (DIR).

Increasing risk
30
Exempt Dealings
  • Notify the IBC of the dealing using the exempt
    form on the IBC website (Edusafe).
  • Start work.
  • You do not need permission of the IBC or the
    OGTR. The only requirement is to notify them.
  • Can apply to have dealings added to the exempt
    list.

31
Exempt Dealing Form
32
Notifiable Low Risk Dealings (NLRD)
  • Obtain form from OGTR website
  • Fill in form and submit to IBC.
  • Proposal is evaluated by the IBC.
  • Cannot start work until permission is granted by
    the IBC.
  • The proposal is approved by the IBC and OGTR
    notified in annual report.

33
Dealings Not Involving Release (DNIR)
  • Submit proposal to IBC.
  • Proposal is evaluated and submitted to OGTR.
  • Proposal is sent out for public consultation.
  • OGTR prepares a Risk Assessment Risk Management
    Plan (RAMP).
  • This is sent out for consultation.
  • The conditions of the proposal are finalised.
  • A licence is issued within 90 working days.
  • Work cannot start until the licence is issued.

34
Dealings Involving Release (DIR)
  • Submit proposal to IBC.
  • Proposal is evaluated and submitted to OGTR.
  • Proposal is sent out for public consultation.
  • OGTR prepares a Risk Assessment Risk Management
    Plan (RAMP).
  • This is sent out for consultation.
  • The conditions of the proposal are finalised.
  • A licence is issued within 180 working days of
    receipt of proposal.
  • Work cannot start until the licence is issued.

35
DIR Considerations
  • Potential for spread through pollen and seeds.
  • Presence of pollinator species.
  • Proximity of compatible species.
  • Persistence in seed bed.
  • Weediness.
  • Proximity to waterways.

36
The application process.
The Regulator
The IBC
NLRD Exempt
DIR DNIR
Applicant
37
If your project involves working with, or
creation of GMOs then
  • Check with your supervisor that appropriate
    permission has been obtained.
  • Projects (unless exempt) will have an OGTR
    reference number. Ask your supervisor for that
    number. This number should be listed alongside
    all organisms used in the project.
  • If permission has not been obtained, then you
    should apply for permission.
  • To do this visit the IBC website
  • Even if your project is exempt you need to notify
    the IBC of the project.
  • Changes to the project should be notified as a
    variation to the licence.
Write a Comment
User Comments (0)
About PowerShow.com